- 2024-08-20 02:16抑制剂Tyrosinase-IN-2|Tyrosinase-IN-2|180864-33-9|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:16抑制剂Tyrosinase-IN-2|Tyrosinase-IN-2|180864-33-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂Tyrosinase-IN-2|Tyrosinase-IN-2|180864-33-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂U-104|U-104|178606-66-1|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:16抑制剂Tyrosinase-IN-1|Tyrosinase-IN-1|1164200-43-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂TVB-3166|TVB-3166|1533438-83-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂Tyrosinase-IN-1|Tyrosinase-IN-1|1164200-43-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:16抑制剂Tyrosinase-IN-1|Tyrosinase-IN-1|1164200-43-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂TVB-3166|TVB-3166|1533438-83-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:16抑制剂TVB-3166|TVB-3166|1533438-83-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂Tuxobertinib|Tuxobertinib|2414572-47-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂Tuxobertinib|Tuxobertinib|2414572-47-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂Tubulin polymerization-IN-15|Tubulin polymerization-IN-15|2055517-66-1|Adamas life|≥98%（以实测数值为准）|
- 2024-08-20 02:16抑制剂Tubulin polymerization-IN-15|Tubulin polymerization-IN-15|2055517-66-1|Adamas life|≥98%（以实测数值为准）|
- 2024-08-20 02:16抑制剂Tuxobertinib|Tuxobertinib|2414572-47-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:16抑制剂TS-011|TS-011|339071-18-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂Tubulin inhibitor 6|Tubulin inhibitor 6|105925-39-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂Tubulin inhibitor 6|Tubulin inhibitor 6|105925-39-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂Tubulin polymerization-IN-15|Tubulin polymerization-IN-15|2055517-66-1|Adamas life|≥98%（以实测数值为准）|
- 2024-08-20 02:16抑制剂Tripolin A|Tripolin A|1148118-92-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
